REFLECTION on World AIDS Day The Biloxi Sun Herald
Treatments are more effective and life expectancy has improved, but when the 25th anniversary of the discovery of HIV/AIDS is observed on Friday as World AIDS Day, misconceptions about the disease persist.
Finding normal ; Teen battles rare enzyme disorder San Antonio Express News
This article was originally published in the San Antonio Express-News on Sept. 24, 2001.
ORENCIA® abatacept Data Demonstrated Improvement In Children And Adolescents With Juvenile Idiopathic Arthritis Medical News Today
Bristol-Myers Squibb Company (NYSE: BMY) today announced results of the double-blind phase of an ongoing study, which show ORENCIA® (abatacept) demonstrated improvement in children with active juvenile idiopathic arthritis (JIA) who have had an inadequate response to one or more disease-modifying [click link for full article]
Early detection key to surviving lung cancer Gazette.Net
Dennis Barry is a statistic, and in his opinion, it’s a good thing. The 51-year-old Brookeville resident got a CT scan as part of an international lung cancer study Holy Cross Hospital participated in starting in 2004. Barry, who smoked from age 15 to 40, discovered he had Stage I lung cancer.
ORENCIAR abatacept or REMICADERinfliximab Demonstrated Superior Efficacy to Placebo at Six Months With ORENCIA PR Newswire via Yahoo! Finance
Bristol-Myers Squibb Company today announced results from a study providing further evidence of the efficacy, safety and durability of response of ORENCIA® through 12 months in adults with moderate to severe rheumatoid arthritis who have had an inadequate response to methotrexate .
ORENCIAR abatacept Data Demonstrated Improvement In Children And Adolescents With Juvenile Idiopathic Arthritis Medical News Today
Bristol-Myers Squibb Company (NYSE: BMY) today announced results of the double-blind phase of an ongoing study, which show ORENCIA(R) (abatacept) demonstrated improvement in children with active juvenile idiopathic arthritis (JIA) who have had an inadequate response to one or more disease-mod [click link for full article]
ORENCIAR abatacept Data Demonstrated Improvement in Children and Adolescents With Juvenile Idiopathic Arthritis as PR Newswire via Yahoo! Finance
Bristol-Myers Squibb Company today announced results of the double-blind phase of an ongoing study, which show ORENCIA® demonstrated improvement in children with active juvenile idiopathic arthritis who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs , such as methotrexate or TNF antagonists, as measured by the ACR's Pediatric criteria for improvement of JIA.
Orencia Efficacy In Adults With Rheumatoid Arthritis, Two-year Data Medical News Today
Bristol-Myers Squibb Company (NYSE: BMY)today announced that two-year data from three Phase III pivotal trials demonstrate the long-term efficacy of ORENCIA(r) (abatacept) inadult patients with moderate to severe rheumatoid arthritis (RA)who havehad an inadequate response to one or more disease-modifyinganti-rheumatic drugs(DMARDs) such as methotrexate and TNF antagonists. [click link for full
Two-Year Data For ORENCIAR abatacept Demonstrate Continued Efficacy In Adults With Rheumatoid Arthritis Medical News Today
Bristol-Myers Squibb Company (NYSE: BMY) today announced that two-year data from three Phase III pivotal trials demonstrate the long-term efficacy of ORENCIA(R) (abatacept) in adult patients with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate and TNF antagonists. [click link for
A Fearful Season: Family Worries About Return of Virus That Ravaged Son RedNova
By David Blackburn, Messenger-Inquirer, Owensboro, Ky. Nov. 9--It's November, and Stephanie Stone is nervous. It's when respiratory syncytial virus means asthmalike symptoms in most children but poses a serious threat for those with weak lungs and/or hearts.

Pneumonia (single case or recurring)
Pneumonia (single case or recurring). Please use a separate complete form for each dog. Age at first symptoms ___________. Describe symptoms:
What are the Signs & Symptoms of Lung Cancer?
Chronic cough that gets worse over time; Constant chest pain; Hemoptysis; Shortness of breath; Recurring pneumonia or bronchitis; Swelling of the neck and
CIRCULAR OF THE MINISTRY OF HEALTH29 APRIL 1994,
It is also possible to make an assumed diagnosis of recurring pneumonia and pulmonary Recurring pneumonia: episode of recurring pneumonia (two or more
[Recurrent eosinophilic pneumonia. Bibliographical review
The literature on the pathological conditions inherent in pulmonary eosinophilias is reviewed from t
Blackwell Synergy: J Intern Med, Vol 251, Issue 3, pp. 278-279
DEAR SIR, A 40-year-old male was referred to our hospital, in August 1999, for an investigation of recurring pneumonia with unconsciousness, pneumonia first
Lung Cancer?? recurring pneumonia/please help. - HealthBoards
Health related message boards offering discussions of numerous health topics including allergies, cancer, diabetes, heart disease, exercise,
Recurring sinus infection
Recurring skin rash, Recurring cold sore. 2738, Recurring bladder infection. Recurring deposit calculator, Recurring pneumonia
Archives of Pneumonia from the The Respiratory Disorders Forum
Recurring self-diagnosed pneumonia · Doctor Perscibed Lung infection Pills help all symptoms but pain and breath! pneumonia-RML still hurts- time frame
Is there any way I can prevent my 4-year-old's recurring pneumonia?
There are other, less common conditions that can cause recurring pneumonia. I think your child deserves some basic tests to eliminate some of these.
Bolus management and aspiration pneumonia in patients with
of recurring aspiration pneumonia in patients with. pseudobulbar dysphagia who were maintained on. pureed foods with liquids following an aspiration pneumonia+recurring: pneumonia+recurring